Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

relapsed/refractory diffuse large B-cell lymphoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

relapsed/refractory diffuse large B-cell lymphoma

MONDO:0000901

Find Clinical TrialsTrials

Overview

A diffuse large B-cell lymphoma characterized by less than 50 percent decrease in lesion size with induction therapy or the appearance of new lesions or the appearance of new lesions after attainment of complete remission.

Clinical Trials25 registered · 9 recruiting

Diagnosis

Biomarker and diagnostic research for relapsed/refractory diffuse large B-cell lymphoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

25 clinical trials registered, 9 recruiting. Interventions under study include drug therapy, biologic therapy, other interventions, and procedural interventions. Pipeline includes 5 PHASE3, 11 PHASE2, 8 PHASE1. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT07409428](https://clinicaltrials.gov/study/NCT07409428)

Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:49 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 25 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Clinical study results	68	39%
Research summaries	22	13%
Patient case studies	22	13%
Laboratory research	18	10%
Disease patterns and progression	18	10%
Testing and diagnosis research	13	7%
New treatment approaches	8	5%
Other research	5	3%

relapsed/refractory diffuse large B-cell lymphoma

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications